BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33730354)

  • 21. Cancer cells as a new source of induced pluripotent stem cells.
    Shamsian A; Sahebnasagh R; Norouzy A; Hussein SH; Ghahremani MH; Azizi Z
    Stem Cell Res Ther; 2022 Sep; 13(1):459. PubMed ID: 36064437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mRNA-Based Genetic Reprogramming.
    Warren L; Lin C
    Mol Ther; 2019 Apr; 27(4):729-734. PubMed ID: 30598301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral-free generation and characterization of a human induced pluripotent stem cell line from dermal fibroblasts.
    Engel M; Balez R; Muñoz SS; Cabral-da-Silva MC; Stevens CH; Bax M; Do-Ha D; Sidhu K; Sachdev P; Ooi L
    Stem Cell Res; 2018 Oct; 32():135-138. PubMed ID: 30278375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient RNA-Based Reprogramming of Disease-Associated Primary Human Fibroblasts into Induced Pluripotent Stem Cells.
    McGrath PS; McGarvey SS; Kogut I; Bilousova G
    Methods Mol Biol; 2020; 2117():271-284. PubMed ID: 31960386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
    Durruthy JD; Sebastiano V
    Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
    Shao Z; Cevallos RR; Hu K
    Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA Roles in Cell Reprogramming Mechanisms.
    Pascale E; Caiazza C; Paladino M; Parisi S; Passaro F; Caiazzo M
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of Polycomb Repressive Complex 2 in Maturation of Induced Pluripotent Stem Cells during Reprogramming of Mouse and Human Fibroblasts.
    Khazaie N; Massumi M; Wee P; Salimi M; Mohammadnia A; Yaqubi M
    PLoS One; 2016; 11(3):e0150518. PubMed ID: 26938987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of iPSC Cell Lines from Patients with Sex Chromosome Aneuploidies.
    Astro V; Adamo A
    Methods Mol Biol; 2024; 2770():185-200. PubMed ID: 38351455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
    Zhang L; Wang Y; Zhang Y; Wang L; Huang H
    Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.
    Lieu PT
    Methods Mol Biol; 2015; 1330():47-54. PubMed ID: 26621588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
    Febbraro F; Chen M; Denham M
    Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
    Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
    Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming of chimpanzee fibroblasts into a multipotent cancerous but not fully pluripotent state by transducing iPSC factors in 2i/LIF culture.
    Lin ZY; Nakai R; Hirai H; Kozuka D; Katayama S; Nakamura SI; Okada S; Kitajima R; Imai H; Okano H; Imamura M
    Differentiation; 2020; 112():67-76. PubMed ID: 32045848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
    Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
    Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
    Ovchinnikov DA; Sun J; Wolvetang EJ
    Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.
    Steichen C; Luce E; Maluenda J; Tosca L; Moreno-Gimeno I; Desterke C; Dianat N; Goulinet-Mainot S; Awan-Toor S; Burks D; Marie J; Weber A; Tachdjian G; Melki J; Dubart-Kupperschmitt A
    Stem Cells Transl Med; 2014 Jun; 3(6):686-91. PubMed ID: 24736403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Insight into Reprogramming Barriers to iPSC Generation.
    Haridhasapavalan KK; Raina K; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2020 Feb; 16(1):56-81. PubMed ID: 31758374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
    Dang J; Rana TM
    Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.